2025 Sanya Rose Culture Festival Grand Opening Romance Illuminates a New Cultural Landmark for the Free Trade Port

04-10

Fully Charged in 5 minutes + 860Wh/kg + 25000W/kg, Wanxiang A 123 Three Products are Launched

Fully Charged in 5 minutes + 860Wh/kg + 25000W/kg, Wanxiang A 123 Three Products are Launched

03-25

The Advent of Icloud Box: Striving to Be the True Leader in the "AI Era"

03-21

Korea's Leading EdTech 'ZEP QUIZ' Officially Launches in Thailand

- ZEP expands to Thailand just a month after entering Indonesia,recording 1 million plays during its beta service period.

03-20

Get a sneak peek at the highlights: Tourism Plus Shanghai 2025 promotes innovation

SHANGHAI,March 19,2025--Recording a new high scale: From March 30th to April 3rd,2025,Tourism Plus Shanghai 2025 will create a new record with five collective exhibitions and four pavilions in Pudong

03-20

Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment

More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO,Calif.,March 19,2025-- Terumo Neuro,a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corpor

03-20

Safe & Together Institute Launches Innovative Online Course for Independent Children's Lawyers in Partnership with National Legal Aid

MELBOURNE,Australia,March 20,2025--The Safe & Together Institute,a global leader in domestic abuse–informed training and implementation,announced today the launch of "Safe & Together: A

03-20

Preserving heritage, embracing innovation: Guizhou's cultural tourism boom

BEIJING,March 19,2025-- A report from People\'s Daily As night fell,a powerful and melodious soprano voice echoed through Zhaoxing Dong village in Liping county,Qiandongnan Miao and Dong autonomous pr

03-20

Xiao-I Corporation Announces Strategic Partnership with TF International to Advance AI-Powered Financial Services

SHANGHAI,March 19,2025-- Xiao-I Corporation (NASDAQ: AIXI),an advanced artificial intelligence company ("Xiao-I"),announced a global strategic partnership with TF International Securities Gr

03-20

Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer

SHANGHAI,March 19,2025-- ShanghaiHenlius Biotech,Inc. (2696.HK) announced that the U.S.Food and Drug Administration(FDA) has granted Orphan Drug Designation (ODD) for HLX22,the company\'s innovativean

03-20